The Artesunate Market is expected to register a CAGR of 6.1% from 2025 to 2031, with a market size expanding from US$ XX million in 2024 to US$ XX Million by 2031.
The Artesunate Market report covers segmental analysis by Type (0.99, 0.98); Form (Tablets, Injection), and Geography (North America, Europe, Asia Pacific, and South and Central America). The global analysis is further broken down at the regional level and major countries. The report Offers the Value in US$ for the above analysis and segments.
Purpose of the ReportThe report Artesunate Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:
- Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
- Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
- Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.
Artesunate Market Segmentation
Type- 0.99
- 0.98
- Tablets
- Injection
Strategic Insights
Artesunate Market Growth Drivers- Rising Malaria Incidence: The Artesunate Market is significantly driven by the rising incidence of malaria worldwide. As the most effective treatment for severe malaria, Artesunate remains a cornerstone in therapeutic solutions. The ongoing fight against malaria, especially in tropical regions like Sub-Saharan Africa and Southeast Asia, boosts the demand for Artesunate injections and oral formulations. Public health initiatives that focus on malaria eradication also fuel the market's expansion.
- Rising Awareness of Malaria Treatment Efficacy: A growing focus on the efficacy of Artesunate in treating severe malaria is propelling its market presence. Healthcare professionals are increasingly recognizing Artesunate as the treatment of choice for uncomplicated and complicated malaria cases due to its fast action and high therapeutic success rates. The increasing awareness of its effectiveness boosts both its utilization and the demand for Artesunate across regions with high malaria burden.
- Prevalence of Antimalarial Resistance: The rising issue of antimalarial resistance is pushing for a continued reliance on Artesunate as an essential treatment. Artesunate's unique mechanism of action against Plasmodium falciparum, the malaria parasite, remains effective even in the face of resistance to other antimalarial drugs. This drives the ongoing demand for Artesunate, positioning it as a critical drug in the fight against resistant malaria strains.
- Repositioning of Artesunate for New Indications: As research into the broader therapeutic potential of Artesunate continues to grow, its use could extend beyond malaria treatment. In the future, Artesunate may be explored for its potential in treating other conditions, such as cancer, viral infections, and parasitic diseases like schistosomiasis. The repurposing of Artesunate to target new indications is expected to drive market growth by opening new therapeutic categories and diversifying its application.
- Sustainability and Green Chemistry in Artesunate Production: Environmental sustainability is becoming a major trend in pharmaceutical manufacturing, including in the Artesunate Market. With increasing pressure to adopt eco-friendly practices, pharmaceutical companies are likely to invest in green chemistry solutions for the production of Artesunate. This includes reducing the environmental footprint of Artesunate synthesis and finding sustainable sourcing of raw materials, such as artemisinin, which is derived from the sweet wormwood plant. The adoption of these sustainable practices will be essential in ensuring the long-term growth and social responsibility of the Artesunate market.
- Enhanced Focus on Malaria Vaccine Integration: With advancements in malaria vaccine development, the Artesunate Market is expected to adapt to a more integrated malaria treatment approach. Artesunate may be combined with new malaria vaccines to form comprehensive treatment protocols that reduce both infection rates and the reliance on antimalarial drugs. This integration of vaccines and treatments like Artesunate will play a key role in tackling malaria on a global scale and could shape future market dynamics.
- Targeting Non-Malaria Endemic Regions with Prophylactic Uses: An emerging opportunity in the Artesunate Market is the potential use of Artesunate in malaria prophylaxis, particularly for travelers or expatriates who visit malaria-endemic regions. As more people travel to these areas, the demand for Artesunate as a preventive treatment can rise. Pharmaceutical companies could explore developing and marketing Artesunate formulations specifically targeted toward these high-risk populations, opening a new niche in the global market.
- Sustainability and Ethical Sourcing of Artemisinin: As the demand for Artesunate grows, there is an opportunity for companies to lead in sustainable practices in the sourcing of artemisinin, the active ingredient in Artesunate. With rising concerns about environmental sustainability and ethical sourcing, manufacturers can capitalize on consumer and industry trends toward eco-friendly and fair-trade practices. By adopting green chemistry methods and supporting ethical sourcing of artemisinin, companies can not only differentiate their products but also strengthen their market position.
- Development of Long-Acting and Injectable Formulations: A promising opportunity for the Artesunate Market lies in the development of long-acting injectable formulations. These formulations would reduce the frequency of administration, improving patient adherence and making it easier to treat malaria in remote and underserved areas. The market for injectable Artesunate could expand significantly, particularly in regions where oral administration is not feasible. Developing more convenient, long-acting forms of Artesunate will also help meet the needs of patients who require more robust, long-term malaria control.
Market Report Scope
Key Selling Points
- Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Artesunate Market, providing a holistic landscape.
- Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
- Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
- Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.
The research report on the Artesunate Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.
REGIONAL FRAMEWORK
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The Artesunate Market is expected to register a CAGR of 6.1% from 2025-2031.
The major factors impacting the Artesunate Market are: Rising Malaria Incidence, Rising Awareness of Malaria Treatment Efficacy and Prevalence of Antimalarial Resistance
Key future trends in this market are - Repositioning of Artesunate for New Indications, Sustainability and Green Chemistry in Artesunate Production and Enhanced Focus on Malaria Vaccine Integration
Key companies of this market are: NHU, Guilin Pharma, KPC Pharmaceuticals, Nanjing Hicin Pharmaceutical, Fuyuan Pharmaceuticals, Kunming Baker Norton Pharmaceutical, MCW Healthcare, Shin Poong, Ipca Laboratories, Acino, Sanofi Aventis, Cipla, Ajanta Pharma, Amivas, Systacare Remedies
The report can be delivered in PDF/PPT format; we can also share excel dataset based on the request.
Some of the customization options available based on request are additional 3–5 company profiles and country-specific analysis of 3–5 countries of your choice. Customizations are to be requested/discussed before making final order confirmation, as our team would review the same and check the feasibility.
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Artesunate Market - By Type
1.3.2 Artesunate Market - By Form
1.3.3 Artesunate Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. ARTESUNATE MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. ARTESUNATE MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. ARTESUNATE MARKET - GLOBAL MARKET ANALYSIS
6.1. ARTESUNATE - GLOBAL MARKET OVERVIEW
6.2. ARTESUNATE - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. ARTESUNATE MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. 0.99
7.3.1. Overview
7.3.2. 0.99 Market Forecast and Analysis
7.4. 0.98
7.4.1. Overview
7.4.2. 0.98 Market Forecast and Analysis
8. ARTESUNATE MARKET - REVENUE AND FORECASTS TO 2028 - FORM
8.1. OVERVIEW
8.2. FORM MARKET FORECASTS AND ANALYSIS
8.3. TABLETS
8.3.1. Overview
8.3.2. Tablets Market Forecast and Analysis
8.4. INJECTION
8.4.1. Overview
8.4.2. Injection Market Forecast and Analysis
9. ARTESUNATE MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Artesunate Market Overview
9.1.2 North America Artesunate Market Forecasts and Analysis
9.1.3 North America Artesunate Market Forecasts and Analysis - By Type
9.1.4 North America Artesunate Market Forecasts and Analysis - By Form
9.1.5 North America Artesunate Market Forecasts and Analysis - By Countries
9.1.5.1 United States Artesunate Market
9.1.5.1.1 United States Artesunate Market by Type
9.1.5.1.2 United States Artesunate Market by Form
9.1.5.2 Canada Artesunate Market
9.1.5.2.1 Canada Artesunate Market by Type
9.1.5.2.2 Canada Artesunate Market by Form
9.1.5.3 Mexico Artesunate Market
9.1.5.3.1 Mexico Artesunate Market by Type
9.1.5.3.2 Mexico Artesunate Market by Form
9.2. EUROPE
9.2.1 Europe Artesunate Market Overview
9.2.2 Europe Artesunate Market Forecasts and Analysis
9.2.3 Europe Artesunate Market Forecasts and Analysis - By Type
9.2.4 Europe Artesunate Market Forecasts and Analysis - By Form
9.2.5 Europe Artesunate Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Artesunate Market
9.2.5.1.1 Germany Artesunate Market by Type
9.2.5.1.2 Germany Artesunate Market by Form
9.2.5.2 France Artesunate Market
9.2.5.2.1 France Artesunate Market by Type
9.2.5.2.2 France Artesunate Market by Form
9.2.5.3 Italy Artesunate Market
9.2.5.3.1 Italy Artesunate Market by Type
9.2.5.3.2 Italy Artesunate Market by Form
9.2.5.4 Spain Artesunate Market
9.2.5.4.1 Spain Artesunate Market by Type
9.2.5.4.2 Spain Artesunate Market by Form
9.2.5.5 United Kingdom Artesunate Market
9.2.5.5.1 United Kingdom Artesunate Market by Type
9.2.5.5.2 United Kingdom Artesunate Market by Form
9.2.5.6 Rest of Europe Artesunate Market
9.2.5.6.1 Rest of Europe Artesunate Market by Type
9.2.5.6.2 Rest of Europe Artesunate Market by Form
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Artesunate Market Overview
9.3.2 Asia-Pacific Artesunate Market Forecasts and Analysis
9.3.3 Asia-Pacific Artesunate Market Forecasts and Analysis - By Type
9.3.4 Asia-Pacific Artesunate Market Forecasts and Analysis - By Form
9.3.5 Asia-Pacific Artesunate Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Artesunate Market
9.3.5.1.1 Australia Artesunate Market by Type
9.3.5.1.2 Australia Artesunate Market by Form
9.3.5.2 China Artesunate Market
9.3.5.2.1 China Artesunate Market by Type
9.3.5.2.2 China Artesunate Market by Form
9.3.5.3 India Artesunate Market
9.3.5.3.1 India Artesunate Market by Type
9.3.5.3.2 India Artesunate Market by Form
9.3.5.4 Japan Artesunate Market
9.3.5.4.1 Japan Artesunate Market by Type
9.3.5.4.2 Japan Artesunate Market by Form
9.3.5.5 South Korea Artesunate Market
9.3.5.5.1 South Korea Artesunate Market by Type
9.3.5.5.2 South Korea Artesunate Market by Form
9.3.5.6 Rest of Asia-Pacific Artesunate Market
9.3.5.6.1 Rest of Asia-Pacific Artesunate Market by Type
9.3.5.6.2 Rest of Asia-Pacific Artesunate Market by Form
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Artesunate Market Overview
9.4.2 Middle East and Africa Artesunate Market Forecasts and Analysis
9.4.3 Middle East and Africa Artesunate Market Forecasts and Analysis - By Type
9.4.4 Middle East and Africa Artesunate Market Forecasts and Analysis - By Form
9.4.5 Middle East and Africa Artesunate Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Artesunate Market
9.4.5.1.1 South Africa Artesunate Market by Type
9.4.5.1.2 South Africa Artesunate Market by Form
9.4.5.2 Saudi Arabia Artesunate Market
9.4.5.2.1 Saudi Arabia Artesunate Market by Type
9.4.5.2.2 Saudi Arabia Artesunate Market by Form
9.4.5.3 U.A.E Artesunate Market
9.4.5.3.1 U.A.E Artesunate Market by Type
9.4.5.3.2 U.A.E Artesunate Market by Form
9.4.5.4 Rest of Middle East and Africa Artesunate Market
9.4.5.4.1 Rest of Middle East and Africa Artesunate Market by Type
9.4.5.4.2 Rest of Middle East and Africa Artesunate Market by Form
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Artesunate Market Overview
9.5.2 South and Central America Artesunate Market Forecasts and Analysis
9.5.3 South and Central America Artesunate Market Forecasts and Analysis - By Type
9.5.4 South and Central America Artesunate Market Forecasts and Analysis - By Form
9.5.5 South and Central America Artesunate Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Artesunate Market
9.5.5.1.1 Brazil Artesunate Market by Type
9.5.5.1.2 Brazil Artesunate Market by Form
9.5.5.2 Argentina Artesunate Market
9.5.5.2.1 Argentina Artesunate Market by Type
9.5.5.2.2 Argentina Artesunate Market by Form
9.5.5.3 Rest of South and Central America Artesunate Market
9.5.5.3.1 Rest of South and Central America Artesunate Market by Type
9.5.5.3.2 Rest of South and Central America Artesunate Market by Form
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. ARTESUNATE MARKET, KEY COMPANY PROFILES
11.1. NHU
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. GUILIN PHARMA
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. KPC PHARMACEUTICALS
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. NANJING HICIN PHARMACEUTICAL
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. FUYUAN PHARMACEUTICALS
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. KUNMING BAKER NORTON PHARMACEUTICAL
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. MCW HEALTHCARE
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. SHIN POONG
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. IPCA LABORATORIES
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. ACINO
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
1. NHU
2. Guilin Pharma
3. KPC Pharmaceuticals
4. Nanjing Hicin Pharmaceutical
5. Fuyuan Pharmaceuticals
6. Kunming Baker Norton Pharmaceutical
7. MCW Healthcare
8. Shin Poong
9. Ipca Laboratories
10. Acino
11. Sanofi Aventis
12. Cipla
13. Ajanta Pharma
14. Amivas
15. Systacare Remedies
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For